CLINICAL AND NEUROLOGICAL FEATURES OF SUBACUTESCLEROSING PANENCEPHALITIS IN CHILDREN
Keywords:
Sclerosing panencephalitis, children, neurological disorders, epileptic seizures, cognitive impairment, disease progression.Abstract
Sclerosing panencephalitis (SP) is a rare but severe progressive disease of the central nervous system in children, characterized by significant neurological impairment and unfavorable prognosis. This study aimed to investigate the clinical and neurological features of SP in children considering patients’ age and duration of the pathological process.
References
Johnson R.T., Griffin D.E. Panencephalitis: pathogenesis and treatment. — New York: Springer, 2020.
Petrov V.V., Smirnova E.G. Pediatric neuroinflammatory diseases: Panencephalitis and variants. — Saint Petersburg, 2016.
Kuznetsova M.L. Demyelination of the central nervous system: clinical and morphological aspects. — Novosibirsk, 2017.
Sidorov N.P. Pediatric neurology. — Moscow: GEOTAR-Med, 2019.
Garg R.K. Subacute sclerosing panencephalitis: current perspectives. Pediatric Neurology. 2021;118:1–8.
Jafri S.K., Kumar R. Clinical spectrum of subacute sclerosing panencephalitis in children. Child's Nervous System. 2022;38(4):745–752.
Mahadevan A., Saini J. Subacute sclerosing panencephalitis: pathogenesis and neuroimaging features. Journal of the Neurological Sciences. 2021;429:119705.
Mishra D., Juneja M. Early clinical predictors of disease progression in SSPE. Seizure. 2023;105:45–50.
World Health Organization (WHO). Measles and associated neurological complications. — Geneva, 2022.
Dyken P.R. Changing epidemiology of subacute sclerosing panencephalitis. Journal of Child Neurology. 2021;36(6):453–457.
